Summary
IDEXX Laboratories, Inc. (IDXX) filed a Form 8-K on January 26, 2007, to report its financial results for the fourth quarter and full year ended December 31, 2006. The report primarily serves to furnish the press release detailing these financial outcomes, which is attached as Exhibit 99.1. Investors should note that this information is furnished under Item 2.02 and is not considered "filed" for purposes of Section 18 of the Exchange Act, meaning it does not carry the same liability as formally filed documents but is still a key source of company performance data. While the 8-K itself does not contain the specific financial figures, it directs investors to the accompanying press release for comprehensive details on the company's operational and financial condition for the reported periods. The filing indicates that the Chief Financial Officer, Merilee Raines, has certified the report, underscoring the official nature of the disclosed results. Investors looking for quantitative performance metrics and management's commentary on the results should refer to the referenced press release.
Key Highlights
- 1IDEXX Laboratories filed an 8-K on January 26, 2007, announcing Q4 and full-year 2006 financial results.
- 2The primary purpose of the filing is to furnish a press release (Exhibit 99.1) with the detailed financial results.
- 3The disclosed information pertains to the quarter and year ended December 31, 2006.
- 4The filing is made under Item 2.02 (Results of Operations and Financial Condition).
- 5Information furnished under Item 2.02 is not deemed 'filed' for Section 18 liability purposes.
- 6The Chief Financial Officer, Merilee Raines, signed the report, indicating official company disclosure.
- 7Investors are directed to the press release for specific financial performance data.